Correlation Between Genovate Biotechnology and Medeon Biodesign

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Genovate Biotechnology and Medeon Biodesign at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Genovate Biotechnology and Medeon Biodesign into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Genovate Biotechnology Co and Medeon Biodesign, you can compare the effects of market volatilities on Genovate Biotechnology and Medeon Biodesign and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Genovate Biotechnology with a short position of Medeon Biodesign. Check out your portfolio center. Please also check ongoing floating volatility patterns of Genovate Biotechnology and Medeon Biodesign.

Diversification Opportunities for Genovate Biotechnology and Medeon Biodesign

0.48
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Genovate and Medeon is 0.48. Overlapping area represents the amount of risk that can be diversified away by holding Genovate Biotechnology Co and Medeon Biodesign in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Medeon Biodesign and Genovate Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Genovate Biotechnology Co are associated (or correlated) with Medeon Biodesign. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Medeon Biodesign has no effect on the direction of Genovate Biotechnology i.e., Genovate Biotechnology and Medeon Biodesign go up and down completely randomly.

Pair Corralation between Genovate Biotechnology and Medeon Biodesign

Assuming the 90 days trading horizon Genovate Biotechnology Co is expected to generate 0.37 times more return on investment than Medeon Biodesign. However, Genovate Biotechnology Co is 2.67 times less risky than Medeon Biodesign. It trades about -0.13 of its potential returns per unit of risk. Medeon Biodesign is currently generating about -0.3 per unit of risk. If you would invest  2,220  in Genovate Biotechnology Co on September 4, 2024 and sell it today you would lose (30.00) from holding Genovate Biotechnology Co or give up 1.35% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Genovate Biotechnology Co  vs.  Medeon Biodesign

 Performance 
       Timeline  
Genovate Biotechnology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Genovate Biotechnology Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Genovate Biotechnology is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.
Medeon Biodesign 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Medeon Biodesign has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Medeon Biodesign is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Genovate Biotechnology and Medeon Biodesign Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Genovate Biotechnology and Medeon Biodesign

The main advantage of trading using opposite Genovate Biotechnology and Medeon Biodesign positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Genovate Biotechnology position performs unexpectedly, Medeon Biodesign can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medeon Biodesign will offset losses from the drop in Medeon Biodesign's long position.
The idea behind Genovate Biotechnology Co and Medeon Biodesign pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.

Other Complementary Tools

Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum